This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Celgene Corporation. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Innovations in Cancer Treatment by Yan Ren
Introduction
Yan Ren is an accomplished inventor based in San Diego, CA, who has made significant contributions to the field of cancer treatment. With a focus on developing methods for determining drug efficacy, Ren's work is particularly relevant for patients suffering from various types of cancers.
Latest Patents
Yan Ren holds a patent for "Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers." This patent outlines methods that utilize certain cereblon-associated proteins, such as Aiolos, Ikaros, and interferon pathway proteins, as biomarkers. These biomarkers are essential for predicting and monitoring clinical sensitivity and therapeutic responses in patients with diseases like diffuse large B-cell lymphoma, multiple myeloma, and acute myeloid leukemia.
Career Highlights
Ren is currently employed at Celgene Corporation, where he continues to advance research in oncology. His innovative approaches have the potential to improve treatment outcomes for patients facing challenging diagnoses.
Collaborations
Yan Ren collaborates with notable colleagues, including Anke Klippel and Courtney G Havens, who contribute to the research and development of cancer therapies.
Conclusion
Yan Ren's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His contributions are paving the way for more effective treatment options for patients in need.